WhiteOak Capital Pharma and Healthcare Fund Regular Growth

+

Invest

Explore On

Equity
Sector - Healthcare
Rating N.A.
Plan

14.16 +0.01 (0.10%) NAV as on 13 Nov, 2025

5D
1M
6M
1Y
5Y
MAX

Key Metrics

AUM (in Cr)480.08
CAGR 11.86%
Exit Load1.00%
Expense ratio2.38%
CategoryEquity
Min Investment500
Min SIP100
Launch Date2024-02-06

Asset Allocation

Holdings As On - 16 November 2025

Holdings

Sectors

Name
Value (Cr)
Holding %

Divi's Laboratories
32.96
6.87%

Fortis Healthcare
30.35
6.32%

Clearing Corporation Of India Ltd
26.39
5.50%

Laurus Labs
22.47
4.68%

Cipla
20.15
4.20%

Neuland Laboratories
18.36
3.82%

Lupin
17.92
3.73%

Sai Life Sciences
14.14
2.94%

Peer Comparison

Fund Name
UTI Healthcare Fund Regular Plan Growth4.22%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth4.13%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth11.86%
Kotak Healthcare Fund Regular Growth2%
Quant Healthcare Fund Regular Growth-1.57%

Risk & Volitility

Alpha 0.00%
Beta 0.00
Sharpe Ratio0.00
Std Deviation 0.00%
Tracking Error 0.00%

About Fund

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.

The WhiteOak Capital Pharma and Healthcare Fund Regular Growth has an AUM of 480.08 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.38%. The minimum investment in WhiteOak Capital Pharma and Healthcare Fund Regular Growth is Rs 500 and the minimum SIP is Rs 100.

As per morningstar the risk & return rating of the fund are Medium & Moderate respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, J B Chemicals and Pharmaceuticals & Fortis Healthcare.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Chemical Manufacturing.

Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, WhiteOak Capital Pharma and Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth, Quant Healthcare Fund Regular Growth. WhiteOak Capital Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.